![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() by Staff Writers Miami (AFP) Aug 5, 2016
A type of genetically modified mosquito made by the British company Oxitec should pose no danger to the environment, US regulators said on Friday after considering thousands of public comments. The US Food and Drug Administration's environmental review for the release of Oxitec's genetically engineered (GE) mosquitoes, known as OX513A, found "the proposed field trial will not have significant impacts on the environment." The male mosquitoes are engineered so that their offspring will die before they reach adulthood, an approach Oxitec says can reduce the populations of Aedes aegypti mosquitoes that can spread human viral diseases, including Zika, dengue, yellow fever and chikungunya. The FDA decision does not, however, mean the mosquitoes are immediately approved for commercial use, said a statement from the federal agency. "Oxitec is responsible for ensuring all other local, state and federal requirements are met before conducting the proposed field trial," said the FDA. The Florida Keys Mosquito Control District will also weigh in on whether and when to begin the proposed field trial in Key Haven, Florida. The program would release male Oxitec mosquitoes to mate with wild female Aedes aegypti. Only female mosquitoes bite and spread disease. Any offspring they produce would soon die, reducing the size of the mosquito population. - 'Exceptional level of control' - "Efficacy trials in Brazil, Panama, and the Cayman Islands have tested this approach, and in each of these trials the population of Aedes aegypti was reduced by more than 90 percent -- an exceptional level of control compared to conventional methods, such as insecticides," said an Oxitec statement. The prospect of releasing the mosquitoes in the Florida Keys has stirred strong opposition among many residents, and a petition against them on change.org has garnered more than 168,000 signatures. The FDA said it had reviewed thousands of comments from the public since issuing a draft environmental assessment in March. "We're delighted with the announcement today that the FDA, after their extensive review of our dossier and thousands of public comments for a trial in the Florida Keys, have published their final view that this will not have a significant impact on the environment," said Oxitec's chief executive officer Hadyn Parry. "We are convinced that our solution is both highly effective and has sound environmental credentials," Parry added. "We are now looking forward to working with the community in the Florida Keys moving forward." Supporters of the modified mosquitoes say they could be a key asset in the fight against Zika, since the mosquitoes that carry the virus can breed in tiny amounts of water, and can be difficult to kill with pesticides. The United States is now among some 50 countries and territories of the world, most of them in Latin America and the Caribbean, where Zika virus is active. Florida has announced 16 locally transmitted cases of the Zika virus since July, with all those cases linked to one neighborhood in Miami. If a pregnant woman is infected with Zika, she faces a higher risk of bearing a child with the permanent skull and brain defect known as microcephaly.
Related Links Epidemics on Earth - Bird Flu, HIV/AIDS, Ebola
|
|
The content herein, unless otherwise known to be public domain, are Copyright 1995-2024 - Space Media Network. All websites are published in Australia and are solely subject to Australian law and governed by Fair Use principals for news reporting and research purposes. AFP, UPI and IANS news wire stories are copyright Agence France-Presse, United Press International and Indo-Asia News Service. ESA news reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. All articles labeled "by Staff Writers" include reports supplied to Space Media Network by industry news wires, PR agencies, corporate press officers and the like. Such articles are individually curated and edited by Space Media Network staff on the basis of the report's information value to our industry and professional readership. Advertising does not imply endorsement, agreement or approval of any opinions, statements or information provided by Space Media Network on any Web page published or hosted by Space Media Network. General Data Protection Regulation (GDPR) Statement Our advertisers use various cookies and the like to deliver the best ad banner available at one time. All network advertising suppliers have GDPR policies (Legitimate Interest) that conform with EU regulations for data collection. By using our websites you consent to cookie based advertising. If you do not agree with this then you must stop using the websites from May 25, 2018. Privacy Statement. Additional information can be found here at About Us. |